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Sympathetic hyperactivity (SH) is a hallmark of heart failure (HF),
and several lines of evidence suggest that SH contributes to HF-
induced skeletal myopathy. However, little is known about the influ-
ence of SH on skeletal muscle morphology and metabolism in a
setting of developing HF, taking into consideration muscles with
different fiber compositions. The contribution of SH on exercise
tolerance and skeletal muscle morphology and biochemistry was
investigated in 3- and 7-mo-old mice lacking both 2A- and 2C-
adrenergic receptor subtypes (2A/2CARKO mice) that present SH
with evidence of HF by 7 mo. To verify whether exercise training
(ET) would prevent skeletal muscle myopathy in advanced-stage HF,
2A/2CARKO mice were exercised from 5 to 7 mo of age. At 3 mo,
2A/2CARKO mice showed no signs of HF and preserved exercise
tolerance and muscular norepinephrine with no changes in soleus
morphology. In contrast, plantaris muscle of 2A/2CARKO mice
displayed hypertrophy and fiber type shift (IIA 3 IIX) paralleled by
capillary rarefaction, increased hexokinase activity, and oxidative
stress. At 7 mo, 2A/2CARKO mice displayed exercise intolerance
and increased muscular norepinephrine, muscular atrophy, capillary
rarefaction, and increased oxidative stress. ET reestablished 2A/
2CARKO mouse exercise tolerance to 7-mo-old wild-type levels and
prevented muscular atrophy and capillary rarefaction associated with
reduced oxidative stress. Collectively, these data provide direct evi-
dence that SH is a major factor contributing to skeletal muscle
morphological changes in a setting of developing HF. ET prevented
skeletal muscle myopathy in 2A/2CARKO mice, which highlights
its importance as a therapeutic tool for HF.
oxidative stress; 2A/2C-adrenergic receptor knockout mice; cardiac
cachexia
HEART FAILURE (HF) is a clinical syndrome with poor prognosis
characterized by exercise intolerance, early fatigue, and skel-
etal muscle myopathy associated with atrophy and shift toward
fast-twitch fibers (27, 28, 49). The development of end-stage
HF often involves a myocardial insult that reduces cardiac
output, which leads to a compensatory increase in sympathetic
nervous activity (4, 5). Although beneficial acutely, chronic
increase of sympathetic activity leads to further pathological
changes in the heart with a progressive deterioration of cardiac
function (7, 24, 38, 39), which is closely related to increased
cardiac oxidative stress (52).
Several lines of evidence suggest that sympathetic hyperac-
tivity also contributes to the skeletal myopathy of HF, since it
leads to chronic vasoconstriction in HF patients (22, 35, 44)
associated with skeletal muscle oxidative stress (34, 46, 53)
and increased concentrations of proinflammatory cytokines
(12, 23). However, little is known about the influence of
sympathetic hyperactivity on skeletal muscle morphology, re-
dox balance, metabolism, and function in a setting of devel-
oping HF taking into consideration muscles with different fiber
compositions.
Exercise training has been established as an adjuvant therapy
for HF, since it counteracts exercise intolerance and improves
quality of life (13, 18, 26). One of the most striking results
achieved by exercise training in HF is a decrease in sympa-
thetic nervous activity (9, 43) associated with decreased oxi-
dative stress, proinflammatory cytokines, and inducible nitric
oxide synthase (iNOS) expression (36). However, the influence
of reduced sympathetic activity by exercise training on skeletal
muscle mass, phenotype, and redox status requires further
investigation.
Our group (2, 42) previously reported that mice lacking 2A-
and 2C-adrenoceptors (2A/2CARKO) develop sympathetic
hyperactivity-induced HF related to exercise intolerance and
cardiac dysfunction with clinical signs of HF such as lung
edema associated with increased mortality at 7 mo of age. In
contrast, at 3 mo of age, 2A/2CARKO mice display pre-
served cardiac function and exercise tolerance (14, 30). There-
fore, these mice represent a good system for better understand-
ing the influence of sympathetic activity on skeletal muscle
morphology, metabolism, and function in different stages of
cardiac disease and the potential beneficial effects of exercise
training on skeletal myopathy.
The present investigation was undertaken to investigate the
relative contribution of sympathetic hyperactivity to disease
stage-related changes in skeletal muscles with different fiber
compositions. In addition, we studied whether exercise training
would prevent skeletal muscle myopathy in advanced-stage
cardiomyopathy. We tested three hypotheses: 1) that sympa-
thetic hyperactivity in 2A/2CARKO mice with preserved
cardiac function can lead to skeletal muscle hypertrophy and
fiber type change toward a more glycolytic phenotype but
preserved exercise tolerance, 2) that sympathetic hyperactivity
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in late-stage HF can aggravate skeletal muscle myopathy,
leading to skeletal muscle atrophy, capillary rarefaction, oxi-
dative stress. and exercise intolerance; and 3) that exercise training
can prevent skeletal muscle myopathy in 2A/2CARKO mice.
METHODS
Study population. A cohort of male congenic 2A/2CARKO mice
in a C57Bl6/J genetic background and their wild-type (WT) controls
were studied at 3 and 7 mo of age. At 3 mo of age, 2A/2CARKO
mice display normal cardiac function (30), but at 7 mo of age, they
present severe cardiac dysfunction associated with exercise intoler-
ance and increased mortality rate (42). To further investigate the
isolated effect of sympathetic nerve activity on skeletal muscle, we
used a different set of congenic FVB mouse strain lacking 2-
adrenoceptor (2KO), which is the main subtype involved in muscular
effects of norepinephrine (33), and their WT control (8). Mice were
maintained in a 12:12-h dark-light cycle and a temperature-controlled
environment (22°C) with free access to standard laboratory chow
(Nuvital Nutrientes, Curitiba, Brazil) and tap water. This study was in
accordance with ethical principles in animal research adopted by the
Brazilian College of Animal Experimentation (www.cobea.org.br). In
addition, this study was approved by the University of Sao Paulo
Ethical Committee (CEP no. 058).
Graded treadmill exercise test. Exercise capacity, estimated by
total distance run, correlates with skeletal muscle work capacity, and
it is a method used for detecting exercise intolerance in HF. Exercise
tolerance was evaluated using a graded treadmill exercise protocol for
mice as previously described (15). Briefly, after being adapted to
treadmill exercises over a week (10 min of exercise per session), mice
were placed in the treadmill streak and allowed to acclimatize for at
least 30 min. Intensity of exercise was increased by 3 m/min (6–33
m/min) every 3 min at 0% grade until exhaustion. The graded
treadmill exercise test was performed in WT and 2A/2CARKO mice
at 3 and 7 mo of age.
Maximal lactate steady-state workload. In HF, lactate accumula-
tion during exercise starts at lower than normal workload (19, 25).
Therefore, we determined in WT and 2A/2CARKO mice at 3 and 7
mo of age the maximal lactate steady-state workload (MLSSw), which
consisted of the highest workload that could be maintained over 28
min of running without continual blood lactate accumulation (blood
lactate varying by 1 mM from 7 to 28 min). Blood samples (25 l)
were taken from the tail vein every 7 min of running for further lactate
measurements (YSI 2300 Sport) as previously described (15).
Cardiovascular measurements. Resting blood pressure (BP) and
heart rate (HR) were determined noninvasively using a computerized
tail-cuff system (BP-2000; Visitech Systems, Apex, NC) described
elsewhere (7). Mice were acclimatized to the apparatus during daily
sessions over 4 days, 1 wk before starting the experimental period.
Catecholamine measurements. Gastrocnemius and plasma norepi-
nephrine were measured by HPLC using ion-pair reverse-phase chro-
matography coupled with electrochemical detection (0.5 V) as de-
scribed by Monte et al. (31).
Skeletal muscle enzyme assay. For enzyme assays, red and white
portions of gastrocnemius muscle and soleus muscle were previously
frozen in liquid nitrogen. Muscles were homogenized (1:10 wt/vol)
using a sampling homogenizer (Tecnal, Sao Paulo, Brazil) with the
appropriate extraction medium for each enzyme. The activities of
hexokinase (EC 2.7.1.1) and citrate synthase (EC 4.1.3.7) were
determined as previously described (11). The extraction medium for
hexokinase contained 50 mM Tris HCl, 1 mM EDTA, 30 mM MgCl2,
and 20 mM -mercaptoethanol at pH 7.4. The extraction medium for
citrate synthase contained 50 mM Tris HCl and 1 mM EDTA at pH
7.4. Hexokinase was assayed by following the rate of change at a
wavelength of 340 nm, and citrate synthase was determined at a
wavelength of 412 nm. All spectrophotometric measurements were
performed using an Ultrospec 3100 pro spectrophotometer (Amer-
sham Pharmacia Biotech, Freiburg, Germany) at 25°C. For all en-
zymes studied, preliminary experiments established that extraction
and assay procedures produced maximum enzyme activities, as de-
scribed previously (10). The enzyme activities are reported as micro-
moles per minute per gram of tissue fresh weight.
Muscle fiber typing and cross-sectional area. Twenty-four hours
after the last exercise training session or the graded treadmill exercise
test, sedentary and trained mice were killed and the calf muscles
(soleus, plantaris, and red and white portions of gastrocnemius) were
harvested, immediately frozen in melting isopentane, and stored in
liquid nitrogen. Frozen muscles were cut into 10-m cross sections
from the proximal to distal region using a cryostat (Micron HM505E;
Zeiss, Walldorf, Germany). Muscle sections were then incubated for
myofibrillar ATPase activity after alkali (myosin ATPase, pH 10.3) or
acid preincubation (myosin ATPase, pH 4.6) as previously described
(6). The myosin ATPase reaction was used to identify the muscle fiber
type. Type I fibers reacted deeply after acid preincubation at pH 4.6
and lightly after formaldehyde pretreatment and alkali preincubation
at pH 10.3. The inverse occurred with type II muscle fibers. Fiber
typing and fiber cross-sectional area were evaluated in whole muscles
at 200 magnification and further analyzed on a digitizing unit
connected to a computer (Image-Pro Plus; Media Cybernetics, Silver
Spring, MD). The total number of each fiber type was counted to
calculate the numerical fiber type composition (I, IIA, IIX, and IIB).
In plantaris, the fibers that could not be clearly identified as I, IIA, IIX,
or IIB were classified as intermediary (they presented light stain at pH
10.3 and a small area). The cross-sectional area of each fiber type was
measured for further calculation of averaged fiber cross-sectional area.
All analyses were conducted by a single observer (A. V. N. Bacurau)
blinded to mouse identity.
Capillary-to-fiber ratio. Capillary-to-fiber ratio of soleus, plantaris,
and white gastrocnemius muscles was evaluated after myofibrillar
ATPase histochemistry reaction at pH 10.3 as previously described
(45). Briefly, capillary-to-fiber ratio was quantified by a 10  10 grid
optically superimposed on each of 5 nonoverlapping fields at 400
magnification, distributed in a random manner using a computer-
assisted morphometric system (Quantimet 500; Leica, Cambridge,
UK). For calculating capillary-to-fiber ratio, the total number of
capillaries was divided by the total number of fibers counted in the
same field. Only vessels with a diameter 10 m were counted,
which would largely comprise capillaries but might also include
terminal arterioles or venules. All analyses were conducted by a single
observer (A. V. N. Bacurau) blinded to mouse identity.
Skeletal muscle redox status. Because reactive oxygen species are
produced in skeletal muscle and related to injury in skeletal myocytes
(23), we evaluated the reduced glutathione-to-oxidized glutathione
ratio (GSH/GSSG) and lipid peroxidation in soleus and plantaris of all
mice studied. GSH/GSSG was determined by HPLC as described
elsewhere (40). In brief, muscle samples were homogenized in cold
buffer (1:20 wt/vol) containing 0.32 M sucrose, 10 mM HEPES, and
1 mM EDTA at pH 7.4 and immediately centrifuged at 10,000 g for
20 min at 4°C. Crude homogenates were mixed with ice-cold 10%
(wt/vol) metaphosphoric acid, incubated for 30 min on ice, and
centrifuged for 20 min at 14,000 g at 4°C. Supernatants were trans-
ferred to autosample vials and injected into a HPLC system, where
samples were separated using a reversed-phase C18 column (5 m,
4.6 150 mm). After HPLC, GSH and GSSG were detected with an
electrochemical detector (Coulochem III; ESA, Chelmsford, MA)
equipped with a two-channel analytical cell. Redox status was de-
scribed as calculated GSH/GSSG.
Skeletal muscle lipid hydroperoxidation measurement. Lipid hy-
droperoxides were evaluated using the ferrous oxidation-xylenol or-
ange technique (FOX2) as previously described (37). Soleus and
plantaris samples were homogenized (1:20 wt/vol) in phosphate-
buffered saline (PBS; 100 mM, pH 7.4) and immediately centrifuged
at 12,000 g for 20 min at 4°C. Briefly, the homogenate was precipi-
tated with trichloroacetic acid (10% wt/vol) and centrifuged at 12,000
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g for 20 min at 4°C. Supernatant was mixed with FOX reagent
containing 250 M ammonium ferrous sulfate, 100 M xylenol
orange, 25 mM H2SO4, and 4 mM butylated hydroxytoluene in 90%
methanol and incubated at room temperature for 30 min. The absor-
bance of the sample was read at a wavelength of 560 nm.
Skeletal muscle protein expression. Immunoblots of 3- and 7-mo-
old WT, 2A/2CARKO, and exercise-trained 2A/2CARKO soleus
and plantaris muscle homogenates were performed according to
Towbin et al. (47). Briefly, muscles frozen in liquid nitrogen were
homogenized in a buffer containing 1 mM EDTA, 1 mM EGTA, 2
mM MgCl2, 5 mM KCl, 25 mM HEPES, pH 7.5, 100 M PMSF, 2
mM DTT, 1% Triton X-100, and protease inhibitor cocktail (1:100;
Sigma, St. Louis, MO). Samples were loaded and subjected to SDS-
PAGE in polyacrylamide gels (10%). After electrophoresis, proteins
were electrotransferred to nitrocellulose membrane (Amersham Bio-
sciences, Piscataway, NJ). Equal loading of samples (25 g) and even
transfer efficiency were monitored with the use of 0.5% Ponceau S
staining of the blotted membrane. The blotted membrane was then
incubated in a blocking buffer (5% nonfat dry milk, 10 mM Tris HCl,
pH 7.6, 150 mM NaCl, and 0.1% Tween 20) for 2 h at room
temperature and then incubated overnight at 4°C with rabbit iNOS
antibody (1:1,000; Abcam, Cambridge, MA). Binding of the primary
antibody was detected with the use of peroxidase-conjugated second-
ary antibodies (anti-rabbit, 1:3,000, for 1.5 h at room temperature) and
developed using enhanced chemiluminescence (Amersham Bio-
sciences) detected by autoradiography. Quantification analysis of
blots was performed with the use of Scion Image software (Scion
based on NIH Image). Targeted bands were normalized to -tubulin
antibody (1:1,000; Santa Cruz Biotechnology, Santa Cruz, CA).
Exercise training protocol. To verify whether exercise training
could prevent skeletal muscle myopathy in 7-mo-old 2A/2CARKO
mice, we performed exercise training in 2A/2CARKO mice aging
from 5 to 7 mo of age. Exercise training consisted of 8 wk of running
on a motor treadmill (ESD model 01; FUNBEC, Sao Paulo, Brazil),
5 days/wk, for 60 min at MLSSw intensity, as described elsewhere
(15). All untrained mice were exposed to treadmill exercise (5 min)
three times a week to become accustomed to exercise protocol and
handling.
Isoproterenol treatment. Using osmotic pumps implanted subcuta-
neously (Alzet model 2002; Durect, Cupertino, CA), we treated WT
and 2KO mice (3 mo of age) for 14 days with isoproterenol (Sigma)
delivered at a rate of 15 mg kg1 day1.
Statistical analysis. All values are means  SE. Two-way analysis
of variance (ANOVA) with post hoc Duncan’s testing (Statistica
software; StatSoft, Tulsa, OK) was used to compare the effect of
genotype (WT and 2A/2CARKO mice or 2KO mice when appro-
priate) and cardiomyopathy stage (3 and 7 mo of age) on distance run,
MLSSw, cardiovascular measurements, citrate synthase and hexoki-
nase maximal activities, muscular norepinephrine levels, capillary-to-
fiber ratio, muscular fiber type distribution and cross-sectional area,
and skeletal muscle redox status. One-way ANOVA with post hoc
Duncan’s testing (Statistica) was used to verify the effect of exercise
training on skeletal muscle biochemical and morphological variables
in 2A/2CARKO mice. Statistical significance was considered
achieved when the value of P was 0.05.
RESULTS
Physiological parameters of mice studied are presented in
Table 1. 2A/2CARKO mice presented resting tachycardia
with no significant change of resting BP compared with age-
matched WT mice. At 3 mo of age, body weight (26  0.5 vs.
25  0.4 g, P  0.05), wet-to-dry lung weight ratio (5.0  0.1
vs. 5.3  0.1, P  0.05), muscular norepinephrine levels
(0.38  0.1 vs. 0.36  0.1 pg/g, P  0.05), and exercise
tolerance were similar between WT and 2A/2CARKO mice,
respectively. In contrast, plasma norepinephrine levels
(4,617  332 vs. 7,121  630 pg/ml, P  0.05) were
significantly higher in 2A/2CARKO than in WT mice. How-
ever, at 7 mo of age, 2A/2CARKO mice displayed reduced
body weight (30  0.3 vs. 28  0.8 g, P  0.05), increased
wet-to-dry lung weight ratio (5.6  0.1 vs. 6.6  0.5, P 
0.05), and increased muscular norepinephrine (0.47  0.1 vs.
13.14  3.8 pg/g, P  0.05) and plasma norepinephrine levels
(4,989  525 vs. 8,175  797 pg/ml, P  0.05), as well as
exercise intolerance, represented by decreased total distance
run and maximal lactate steady-state workload (Table 1).
Metabolic enzymes and skeletal muscle capillary-to-fiber
ratio. To verify the glycolytic capacity in white muscle of WT
and 2A/2CARKO mice, we evaluated the hexokinase maxi-
mal activity. At 3 mo of age, 2A/2CARKO mice presented an
increased hexokinase maximal activity in the white portion of
gastrocnemius compared with age-matched WT mice (28.8 
3.0 vs. 23.2  0.7 mol min1 g tissue fresh weight1, P 
0.05). At 7 mo of age, hexokinase activity was not different
between 2A/2CARKO and WT mice. Exercise training did
not change hexokinase activity in 2A/2CARKO mice. To
verify the oxidative capacity in red and white muscles, we
evaluated the citrate maximal activity of WT and 2A/
2CARKO mice. Citrate synthase maximal activity was similar
within mice studied at 3 mo of age. In contrast, 7-mo-old
2A/2CARKO mice presented lower maximal citrate synthase
activity in soleus and red gastrocnemius muscles than age-
matched WT mice (Fig. 1, A and B). This response was
restricted to red muscles, since no change was observed in
citrate synthase maximal activity in white gastrocnemius mus-
cle (Fig. 1C). Exercise-trained 2A/2CARKO mice presented
increased (70.4%) citrate synthase activity in red gastrocne-
mius muscle compared with untrained 2A/2CARKO mice
(Fig. 1B), whereas no significant change was observed in white
Table 1. Physiological parameters in WT and 2A/2CARKO mice
3 mo 7 mo
WT ARKO WT ARKO ARKOT
HR, beats/min 5617.6 (29) 6427.3*(15) 5818.4 (16) 6907.2†‡ (15) 5871§ (15)
BP, mmHg 1101.9 (29) 1113.1 (15) 1122.2 (16) 1111.7 (15) 11513 (15)
Distance run, m 40328 (9) 36219 (21) 35418 (16) 23521†‡ (14) 37812§ (14)
MLSSw, m/min 150.8 (8) 150.7 (10) 150.3 (12) 120.3†‡ (11) 190.5‡§ (6)
Values are means  SE of heart rate (HR), blood pressure (BP), and maximal lactate steady-state workload (MLSSw) in wild-type (WT) and
2A/2C-adrenoceptor knockout (2A/2CARKO) mice (ARKO group). In addition, the exercise training effect was evaluated in ARKO mice (ARKOT group).
The number of animals studied in each group is shown in parentheses. *P  0.05 vs. 3-mo-old WT. †P  0.05 vs. 3-mo-old ARKO. ‡P  0.05 vs. 7-mo-old
WT. §P  0.05 vs. 7-mo-old ARKO.
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gastrocnemius muscle (Fig. 1C). This response was paralleled
by an improved exercise tolerance in 2A/2CARKO mice
compared with age-matched untrained 2A/2CARKO mice
(377  6 vs. 235  2 m, respectively, P  0.05).
Capillary-to-fiber ratio was evaluated in soleus, plantaris,
and white gastrocnemius muscle. At 3 mo of age, no difference
was observed in capillary-to-fiber ratio in soleus muscle of
2A/2CARKO mice (Fig. 1D), whereas a capillary rarefaction
could already be observed in plantaris and white gastrocnemius
(Fig. 1, E and F).
The reduced skeletal muscle oxidative activity in red mus-
cles of 7-mo-old 2A/2CARKO mice was paralleled by cap-
illary rarefaction in all muscles studied (Fig. 1, D–F), and
exercise training increased capillary-to-fiber ratio of 2A/
2CARKO to values similar to those observed in WT mice.
Fiber-type distribution and cross-sectional area. The stain-
ing patterns of the fibers are shown in plantaris and soleus
muscles (Fig. 2, A–D).In soleus muscle, there was no differ-
ence in percentage of type I, IIA, and IIX fiber distribution
between 3-mo-old WT and 2A/2CARKO mice (Fig. 3A). In
contrast, 7-mo-old 2A/2CARKO mice presented decreased
type I and IIX fibers but increased type IIA fiber, which
suggests a shift toward type II fiber in advanced-stage cardio-
myopathy (Fig. 3A). In plantaris muscle, the shift toward more
glycolytic fibers in 2A/2CARKO could be observed as early
as 3 mo of age (Fig. 3B). 2A/2CARKO mice presented a
decreased percentage of type IIA and increased type IIX and
intermediary fiber types compared with age-matched WT mice
(Fig. 3B). However, no further differences in plantaris muscle
composition were observed between WT and 2A/2CARKO
mice at 7 mo of age (Fig. 3B). Exercise training prevented
changes in soleus fiber type composition of 2A/2CARKO
mice (Fig. 3A) and reduced type IIB fibers in plantaris while
increasing type IIX fibers, which suggests a shift back toward
less glycolytic fibers (Fig. 3A).
Cross-sectional area of fibers I, IIA, and IIX in soleus
muscle was not different between WT and 2A/2CARKO
mice at 3 mo of age (Fig. 4, A–C). However, in soleus muscle
of 7-mo-old 2A/2CARKO mice with severe cardiomyopathy,
cross-sectional area was lower than that of age-matched WT
mice (Fig. 4, A–C). Interestingly, cross-sectional area of plan-
taris type IIA and IIB fibers in 3-mo-old 2A/2CARKO mice
was greater than that in age-matched WT mice (Fig. 4, D and
E). Conversely, 7-mo-old 2A/2CARKO mice displayed plan-
taris IIA and IIX fiber atrophy compared with age-matched WT
mice (Fig. 4, D and F). The same pattern of response in
2A/2CARKO mice (hypertrophy at 3 mo followed by atrophy
at 7 mo of age) was observed when the whole plantaris muscle
cross-sectional area was evaluated (data not shown). Exercise
training prevented soleus and plantaris muscles atrophy, since
Fig. 1. Citrate synthase maximal activity in soleus (A) and
red (B) and white gastrocnemius muscles (C) and capillary-
to-fiber ratio in soleus (D), plantaris (E), and white gastroc-
nemius muscles (F). Measurements were performed in 3-
and 7 mo-old wild-type (WT) and 2A/2C-adrenergic re-
ceptor knockout (2A/2CARKO) mice (ARKO group). In
addition, the effect of exercise training on citrate synthase
activity and capillarity was evaluated in 2A/2CARKO
mice (ARKOT group). Citrate synthase activity in the
ARKOT group was restricted to red and white portions of
gastrocnemius, since samples of soleus were scarce in this
group. Note that at 7 mo of age, 2A/2CARKO mice
displayed vascular rarefaction and lower citrate synthase
maximal activity in red muscles than did WT mice. Interestingly,
exercise training prevented both capillary rarefaction and im-
paired citrate synthase activity in 2A/2CARKO mice. Data are
meansSE; the number of animals studied is indicated in the bar
representing each group. *P 0.05 vs. 3-mo-old WT. †P 0.05
vs. 3-mo-old ARKO. ‡P 0.05 vs. 7-mo-old WT. §P 0.05 vs.
7-mo-old ARKO.
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it significantly increased cross-sectional area of most fibers
studied of both muscles (Fig. 4).
Isoproterenol treatment. To investigate the isolated effect of
sympathetic nerve activity on skeletal muscle morphology, we
treated WT and 2KO mice with isoproterenol for 14 days. We
hypothesized that early skeletal muscle hypertrophy, observed
in 3-mo-old 2A/2CARKO mice, is mediated by 2-adreno-
ceptor, which is the main subtype involved in muscular effects
of norepinephrine. In fact, 2KO mice displayed reduced
soleus and plantaris mass paralleled by decreased cross-sec-
tional area of type I and IIA fibers compared with age-matched
WT mice (Table 2). In addition, 2-adrenoceptor deletion
markedly suppressed skeletal muscle enlargement and type I
and IIA fiber hypertrophy observed in WT mice treated with
isoproterenol (Table 2), suggesting a positive role of 2-
adrenoceptor on skeletal muscle hypertrophy.
Fig. 2. Examples of transverse muscle sec-
tions from C57BL6J mice, with histochem-
ical staining for myosin ATPase, preincu-
bated at pH 4.6 in plantaris (A) and soleus
muscles (C) and at pH 10.3 in plantaris (B)
and soleus muscles (D). Fiber types I, IIA,
IIX, and IIB were identified in soleus mus-
cle, and fiber types IIA, IIX, and IIB were
identified in plantaris muscle. Capillaries
(arrows) from white gastrocnemius (E),
plantaris (F), and soleus muscle (G) sections
at pH 10.3 are shown.
1635SKELETAL MUSCLE MASS AND REDOX BALANCE AFTER EXERCISE TRAINING IN HEART FAILURE
J Appl Physiol • VOL 106 • MAY 2009 • www.jap.org
Markers of oxidative stress. Changes in muscle morphology
and function in HF are associated with changes in skeletal
muscle redox status (1). GSH/GSSG was decreased in 3-mo-
old 2A/2CARKO mice compared with age-matched WT
mice in both soleus and plantaris muscles. This decrease in
GSH/GSSG remained in 7-mo-old 2A/2CARKO mice (Fig. 5, A
and B). Exercise training restored redox status of 2A/2CARKO
mice to levels in age-matched WT mice (Fig. 5, A and B).
Lipid hydroperoxidation was similar between 3-mo-old
2A/2CARKO and WT mice (Fig. 5, C and D). In contrast, at
7 mo of age, when cardiomyopathy was in an advanced stage,
lipid hydroperoxidation was significantly increased in 2A/
2CARKO mice (Fig. 5, C and D). Of interest, exercise training
reduced lipid hydroperoxides to levels in WT mice (Fig. 5, C
and D).
iNOS expression was increased in 3-mo-old 2A/2CARKO
mice compared with age-matched WT mice in both soleus and
plantaris muscles. This increased iNOS expression remained in
7-mo-old 2A/2CARKO mice (Fig. 5, E and F). Exercise
training restored iNOS expression of 2A/2CARKO mice to
levels in age-matched WT mice (Fig. 5, E and F).
DISCUSSION
The chronic activation of the sympathetic nervous system
has been postulated to contribute to exercise intolerance and
skeletal muscle myopathy in HF (34). Excessive vasoconstric-
tion by chronic sympathetic hyperactivity adversely affects
muscle performance in HF by altering metabolic status and
limiting oxygen supply to exercising muscle (22). Indeed,
chronic imbalance of the autonomic nervous system is also
present in early stages of cardiac dysfunction when no signs of
HF are observed. In the present investigation, we used genet-
ically modified mice based on the disruption of both 2A- and
2C-adrenoceptors to study the influence of sympathetic hy-
peractivity on disease-stage skeletal muscle changes and the
relative contribution of exercise training in counteracting the
skeletal muscle myopathy in advanced-stage HF.
The key findings of the present study are that sympathetic
hyperactivity in early-stage cardiomyopathy leads to plantaris
hypertrophy associated with preserved muscular norepineph-
rine levels and exercise tolerance but with capillary rarefaction,
a shift toward fast fibers, decreased GSH/GSSG, and increased
hexokinase maximal activity in white gastrocnemius. Con-
versely, chronic sympathetic hyperactivity associated with HF
in 2A/2CARKO mice led to soleus and plantaris atrophy
paralleled by increased muscular norepinephrine levels, exer-
cise intolerance, reduced MLSSw, changes in fiber type distri-
bution, and reduced oxidative capacity in red muscles with
capillary rarefaction and muscular oxidative stress. Remark-
able was the fact that exercise training increased soleus and
plantaris cross-sectional area, preventing skeletal muscle my-
opathy in advanced-stage cardiomyopathy of 2A/2CARKO
mice.
The sympathetic nervous system, through interaction of
norepinephrine released from nerve terminals with 2-adreno-
ceptors, exerts anabolic action on skeletal muscle protein
metabolism (16, 20, 32, 51). In fact, we provide direct evidence
for the involvement of 2-adrenoceptor in skeletal muscle
hypertrophy (Table 2). In addition, our findings show that
hypertrophic effect observed in 3-mo-old 2A/2CARKO mice
might be associated mainly with increased circulating catechol-
amine levels, since no difference was observed in muscular
norepinephrine levels compared with age-matched WT mice.
Indeed, a moderated shift of the redox homeostasis toward a
prooxidant state presently demonstrated by reduced GSH/
GSSG and increased iNOS expression levels in 3-mo-old
2A/2CARKO mice might contribute to skeletal muscle hy-
pertrophy, since proanabolic pathways are activated by redox
signaling (46, 48). This hypertrophic effect was restricted to
type II plantaris muscle fibers of 2A/2CARKO mice with no
alterations observed in soleus muscle despite the fact that
2-adrenoceptor density is reported to be two- to-threefold
higher in red compared with white muscles (17). This finding
Fig. 3. Fiber type distribution in soleus type I, type IIA, and type IIX fibers (A)
and in plantaris type IIA, type IIX, and type IIB fibers (B). Measurements were
performed in 3- and 7-mo-old WT and 2A/2CARKO mice. In addition,
the effect of exercise training on fiber type distribution was evaluated in
2A/2CARKO mice (ARKOT). Note that at 3 mo of age, 2A/2CARKO mice
displayed a shift toward type IIX fibers. In contrast, 7-mo-old 2A/2CARKO
mice displayed shift toward type IIA fibers in soleus muscle. Interestingly,
exercise training in 2A/2CARKO mice prevented phenotype changes in
soleus but increased type IIX fibers in plantaris muscle. Data are means  SE;
the number of animals studied is indicated in the bar representing each group.
*P  0.05 vs. 3-mo-old WT. †P  0.05 vs. 3-mo-old ARKO. ‡P  0.05 vs.
7-mo-old WT. §P  0.05 vs. 7-mo-old ARKO.
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is probably due to the higher downregulation of 2-adrenocep-
tors in red than white muscles (17, 21). 2-Adrenoceptor
activation, through 2-agonists, increases twitch-tension and
glycogenolysis in fast fibers (20, 41). This may occur in
3-mo-old 2A/2CARKO mice, since we observed increased
hexokinase activity restricted to white muscles paralleled by an
augmented percentage of fast fibers and a reduced capillary-
to-fiber ratio. The aforementioned changes in plantaris pheno-
type precede skeletal muscle myopathy and clinical signs of
HF, since 3-mo-old 2A/2CARKO mice displayed a preserved
wet-to-dry lung weight ratio, exercise tolerance, and spontane-
ous locomotor activity as evaluated by open-field test (Supple-
mental Fig. 1). (Supplemental data for this article is available
online at Journal of Applied Physiology website.) Indeed, we
previously demonstrated that 3-mo-old 2A/2CARKO mice
present preserved cardiac function compared with age-matched
WT mice (28).
Although short-term use of 2-adrenoceptor agonists has
been recommended for therapeutic purposes related to func-
tional recovery after skeletal muscle trauma (3), chronic ad-
ministration of sympathomimetics leads to 2-adrenoceptor-
mediated skeletal myotoxicity and loss of its potential muscu-
lar benefits (21, 29). In fact, we observed that chronic
sympathetic hyperactivity induced skeletal muscle myopathy
in 7-mo-old 2A/2CARKO mice associated with a more ex-
tensively prooxidant state marked by increased muscular nor-
epinephrine levels associated with decreased redox balance and
increased lipid hydroperoxidation and iNOS expression. It is
Fig. 4. Cross-sectional area (CSA) of soleus type I (A), type IIA (B), and type IIX fibers (C) and plantaris type IIA (D), type IIB (E), and type IIX fibers (F).
Measurements were performed in 3- and 7-mo-old WT and 2A/2CARKO mice. In addition, the effect of exercise training on fiber CSA was evaluated in
2A/2CARKO mice (ARKOT). Note that at 3 mo of age, 2A/2CARKO mice showed increased CSA of plantaris muscle. In contrast, 7-mo-old 2A/2CARKO
mice displayed atrophy in both soleus and plantaris muscles. Interestingly, exercise training prevented muscle atrophy in 2A/2CARKO mice. Data are means
SE; the number of animals studied is indicated in the bar representing each group. *P  0.05 vs. 3-mo-old WT. †P  0.05 vs. 3-mo-old ARKO. ‡P  0.05
vs. 7-mo-old WT. §P  0.05 vs. 7-mo-old ARKO.
Table 2. Effect of 15 days of isoproterenol treatment on body mass, muscle mass, muscle cross-sectional area, and muscle
fiber type distribution in WT and 2KO mice
Characteristics WT 2KO WTiso 2KOiso
Body weight, g 281.8 (9) 250.9 (13) 330.5 (3) 280.5 (4)
Soleus mass, mg/g 0.250.01 (5) 0.150.01*(7) 0.310.02*(3) 0.180.02‡ (3)
Plantaris mass, mg/g 0.510.01 (4) 0.360.02*(7) 0.660.03*(3) 0.390.01‡ (6)
Soleus fiber type distribution, %
Type I 601.4 (4) 620.5 (4) 561.5 (3) 674.8† (3)
Type IIA 381.2 (4) 322.2 (4) 373.5 (3) 293.6‡ (3)
Type IIX 1.70.3 (4) 5.72.4 (4) 5.12.7 (3) 3.01.7 (3)
Soleus cross-sectional area, m2
Type I 86749 (4) 67019*(4) 1,01434*(3) 73222‡ (3)
Type IIA 69551 (4) 57632*(4) 86518*(3) 6564‡ (3)
Type IIX 759116 (4) 58238 (4) 742118 (3) 54195 (3)
Values are means  SE from WT and 2-adrenoceptor knockout (2KO) mice before and after treatment with isoproterenol (WT iso and 2KOiso). The
number of animals studied in each group is showm in parentheses. *P  0.05 vs. WT. †P  0.05 vs. 2KO. ‡P  0.05 vs. WTiso.
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important to highlight that advanced-stage HF led to significant
global changes in both red and white muscles, such as muscle
bulk loss, capillary rarefaction, and reduced citrate synthase
activity in red muscles of 7-mo-old 2A/2CARKO mice,
which suggests blunted oxidative metabolism paralleled by
fiber type composition toward faster fibers. Together, these
results suggest that 7-mo-old 2A/2CARKO mice present
cardiac cachexia aggravated by reduced locomotion as ob-
served in an open-field test of 7-mo-old 2A/2CARKO mice
(Supplemental Fig. 1). In fact, neurohumoral imbalance in
chronic HF together with increased circulating and local in-
flammation leads to increased iNOS expression and muscular
reactive oxygen species, which ultimately play an important
role in skeletal muscle wasting (23). It is possible that in-
creased skeletal muscle oxidative stress also contributes to the
typical sign of early muscle fatigue presently verified by
reduced exercise tolerance and MLSSw in 7-mo-old 2A/
2CARKO mice.
We have previously reported that exercise training in 2A/
2CARKO mice reduces cardiac sympathetic tone (14), plasma
norepinephrine (42), and resting tachycardia paralleled by
increased ventricular function (14, 42). Presently, we report
that the beneficial effects of exercise training are extended to
skeletal muscle with different fiber type compositions, since
increased fiber cross-sectional area toward WT mice levels is
paralleled by reduced local oxidative stress in both red and
white muscles. This response might be related to decreased
sympathetic activity to skeletal muscle that could lead to a
reduced local oxidative stress and an increased 2-adrenocep-
tor density. In fact, exercise training has been reported to exert
long-term antioxidative effects in mixed-fiber type vastus late-
ralis of HF patients (23) and to increase 2-adrenoceptor
density in gastrocnemius and soleus of running-trained rats (50).
It is important to point out that the prevention of skeletal
muscle atrophy in 2A/2CARKO mice occurs even with mice
exercising under a predominantly aerobic exercise training
regimen, which suggests a homeostatic role of exercise training
in restoring skeletal muscle mass when associated with muscle
atrophy states. The effect of aerobic exercise training in this
genetic model of HF is also observed as increased activity of
citrate synthase in red portion of gastrocnemius paralleled by
increased capillaries per muscle fiber. Altogether, these struc-
Fig. 5. Reduced glutathione-to-oxidized gluta-
thione ratio (GSH/GSSG) in soleus (A) and
plantaris muscles (B), lipid hydroperoxidation
in soleus (C) and plantaris muscles (D), and
inducible nitric oxide synthase (iNOS) protein
expression levels in soleus (E) and plantaris
muscles (F). Measurements were performed in
3- and 7-mo-old WT and 2A/2CARKO mice.
In addition, the effect of exercise training on
muscle redox status and iNOS protein expres-
sion was evaluated in 2A/2CARKO mice
(ARKOT). Note that 3-mo-old 2A/2CARKO
mice already displayed decreased GSH/GSSG
and increased iNOS protein expression com-
pared with age-matched WT mice. At 7 mo of
age, 2A/2CARKO mice presented a global
oxidative stress represented by a decreased
GSH/GSSG and increased lipid hydroperoxi-
dation and iNOS protein expression in both
plantaris and soleus muscles. Interestingly, ex-
ercise training restored redox status in 2A/
2CARKO mice. Data are means  SE; the
number of animals studied is indicated in the
bar representing each group. *P  0.05 vs.
3-mo-old WT. †P 0.05 vs. 3-mo-old ARKO.
‡P  0.05 vs. 7-mo-old WT. §P  0.05 vs.
7-mo-old ARKO.
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tural and metabolic changes induced by exercise training con-
tribute to improved exercise capacity and later fatigue by
increased MLSSw in 7-mo-old 2A/2CARKO mice.
Study limitations. Our study suggests that chronic sympa-
thetic activation in advanced-stage cardiomyopathy of 2A/
2CARKO mice is associated with skeletal muscle atrophy.
However, we cannot exclude the possibility that inactivity
would be a potential factor aggravating skeletal muscle atrophy
and changed phenotype in 7-mo-old ARKO mice with HF.
Therefore, sympathetic hyperactivity can be considered a ma-
jor factor aggravating HF-induced skeletal muscle myopathy.
In summary, the present findings provide evidence for the
dichotomy involving the contribution of sympathetic hyperac-
tivity on skeletal muscle plasticity. Although sympathetic ac-
tivation associated with a moderated prooxidant state led to
hypertrophy of plantaris with preserved exercise tolerance in
3-mo-old 2A/2C ARKO mice, chronic activation of sympa-
thetic nervous system in this genetic model was associated to
red and white muscle atrophy, increased local norepinephrine
levels, and oxidative stress associated with clinical signs of HF
in 2A/2CARKO mice at 7 mo of age. Finally, exercise
training by restoring skeletal muscle mass, metabolism, redox
state, and muscular phenotype can be considered an important
therapeutic strategy for preventing or reversing skeletal muscle
myopathy in HF.
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